Clinical Trial Update: Efficacy and Safety of Diclofenac Potassium 25 mg Tablet Taken Three Times Daily in Subjects With Acute Joint Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of diclofenac potassium 25 mg taken three times daily for acute joint pain in patients with ankle spra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankle Sprain

Drugs mentioned

• DICLOFENAC POTASSIUM (diclofenac potassium)

Snippet

Sponsor: Novartis | Conditions: Ankle Sprain | Phase 4 | Status: COMPLETED | Results posted: 2014-03-27